Advertisement
Screener

ENANTA PHARMACEUTICALS, INC (ENTA) Increase (Decrease) in Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

ENANTA PHARMACEUTICALS, INC Increase (Decrease) in Accrued Liabilities

ENANTA PHARMACEUTICALS, INC (ENTA) reported Increase (Decrease) in Accrued Liabilities of -$2.57 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-12

  • ENANTA PHARMACEUTICALS, INC increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $3.32M, a 31.75% increase year-over-year.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$716.00K.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$5.18M.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $2.42M, a 502.99% increase year-over-year.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in accrued liabilities for fiscal 2025 was $58.00K.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in accrued liabilities for fiscal 2024 was -$5.65M.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in accrued liabilities for fiscal 2023 was -$2.56M.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in accrued liabilities for fiscal 2022 was -$1.48M, a 117.69% decline from fiscal 2021.
Period endIncrease (Decrease) in Accrued Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities 12 month
2026-06-30$3.32M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12
$2.61M
derived: sum of 2 quarters · filed 2026-08-12
-$2.57M
10-Q · filed 2026-08-12
-$150.00K
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31-$716.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13
-$5.89M
10-Q · filed 2026-05-13
-$3.47M
derived: sum of 3 quarters · filed 2026-05-13
-$951.00K
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31-$5.18M
10-Q · filed 2026-02-11
-$2.76M
derived: sum of 2 quarters · filed 2026-02-11
-$235.00K
derived: sum of 3 quarters · filed 2026-08-12
-$2.21M
derived: sum of 4 quarters · filed 2026-08-12
2025-09-30$2.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19
$4.94M
derived: sum of 2 quarters · filed 2026-08-12
$2.97M
derived: sum of 3 quarters · filed 2026-08-12
$58.00K
10-K · filed 2025-11-19
2025-06-30$2.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12
$550.00K
derived: sum of 2 quarters · filed 2026-08-12
-$2.36M
10-Q · filed 2026-08-12
-$1.96M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31-$1.97M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13
-$4.88M
10-Q · filed 2026-05-13
-$4.48M
derived: sum of 3 quarters · filed 2026-05-13
-$2.82M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$2.91M
10-Q · filed 2026-02-11
-$2.51M
derived: sum of 2 quarters · filed 2026-02-11
-$847.00K
derived: sum of 3 quarters · filed 2026-02-11
-$1.82M
derived: sum of 4 quarters · filed 2026-02-11
2024-09-30$401.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19
$2.06M
derived: sum of 2 quarters · filed 2025-11-19
$1.09M
derived: sum of 3 quarters · filed 2025-11-19
-$5.65M
10-K · filed 2025-11-19
2024-06-30$1.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-13
$689.00K
derived: sum of 2 quarters · filed 2025-08-13
-$6.05M
10-Q · filed 2025-08-13
-$5.25M
derived: sum of 4 quarters · filed 2025-11-19
2024-03-31-$973.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14
-$7.71M
10-Q · filed 2025-05-14
-$6.92M
derived: sum of 3 quarters · filed 2025-11-19
-$4.21M
derived: sum of 4 quarters · filed 2025-11-19
2023-12-31-$6.74M
10-Q · filed 2025-02-12
-$5.94M
derived: sum of 2 quarters · filed 2025-11-19
-$3.24M
derived: sum of 3 quarters · filed 2025-11-19
-$2.69M
derived: sum of 4 quarters · filed 2025-11-19
2023-09-30$792.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19
$3.49M
derived: sum of 2 quarters · filed 2025-11-19
$4.04M
derived: sum of 3 quarters · filed 2025-11-19
-$2.56M
10-K · filed 2025-11-19
2023-06-30$2.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-07
$3.25M
derived: sum of 2 quarters · filed 2024-08-07
-$3.35M
10-Q · filed 2024-08-07
-$1.57M
derived: sum of 4 quarters · filed 2024-11-27
2023-03-31$547.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08
-$6.05M
10-Q · filed 2024-05-08
-$4.28M
derived: sum of 3 quarters · filed 2024-11-27
-$6.72M
derived: sum of 4 quarters · filed 2024-11-27
2022-12-31-$6.60M
10-Q · filed 2024-02-08
-$4.82M
derived: sum of 2 quarters · filed 2024-11-27
-$7.27M
derived: sum of 3 quarters · filed 2024-11-27
-$12.28M
derived: sum of 4 quarters · filed 2024-11-27
2022-09-30$1.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27
-$669.00K
derived: sum of 2 quarters · filed 2024-11-27
-$5.68M
derived: sum of 3 quarters · filed 2024-11-27
-$1.48M
10-K · filed 2024-11-27
2022-06-30-$2.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08
-$7.46M
derived: sum of 2 quarters · filed 2023-08-08
-$3.25M
10-Q · filed 2023-08-08
$1.43M
derived: sum of 4 quarters · filed 2023-11-22
2022-03-31-$5.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-09
-$808.00K
10-Q · filed 2023-05-09
$3.87M
derived: sum of 3 quarters · filed 2023-11-22
$5.84M
derived: sum of 4 quarters · filed 2023-11-22
2021-12-31$4.21M
10-Q · filed 2023-02-08
$8.88M
derived: sum of 2 quarters · filed 2023-11-22
$10.85M
derived: sum of 3 quarters · filed 2023-11-22
$15.05M
derived: sum of 4 quarters · filed 2023-11-22
2021-09-30$4.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-22
$6.65M
derived: sum of 2 quarters · filed 2023-11-22
$10.85M
derived: sum of 3 quarters · filed 2023-11-22
$8.35M
10-K · filed 2023-11-22
2021-06-30$1.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-08
$6.17M
derived: sum of 2 quarters · filed 2022-08-08
$3.67M
10-Q · filed 2022-08-08
$4.24M
derived: sum of 4 quarters · filed 2022-11-23
2021-03-31$4.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-09
$1.70M
10-Q · filed 2022-05-09
$2.27M
derived: sum of 3 quarters · filed 2022-11-23
$5.92M
derived: sum of 4 quarters · filed 2022-11-23
2020-12-31-$2.50M
10-Q · filed 2022-02-10
-$1.93M
derived: sum of 2 quarters · filed 2022-11-23
$1.72M
derived: sum of 3 quarters · filed 2022-11-23
$2.12M
derived: sum of 4 quarters · filed 2022-11-23
2020-09-30$568.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-23
$4.22M
derived: sum of 2 quarters · filed 2022-11-23
$4.62M
derived: sum of 3 quarters · filed 2022-11-23
-$1.37M
10-K · filed 2022-11-23
2020-06-30$3.65M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-09
$4.05M
derived: sum of 2 quarters · filed 2021-08-09
-$1.94M
10-Q · filed 2021-08-09
-$142.00K
derived: sum of 4 quarters · filed 2021-11-24
2020-03-31$404.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-10
-$5.58M
10-Q · filed 2021-05-10
-$3.79M
derived: sum of 3 quarters · filed 2021-11-24
-$1.09M
derived: sum of 4 quarters · filed 2021-11-24
2019-12-31-$5.99M
10-Q · filed 2021-02-09
-$4.20M
derived: sum of 2 quarters · filed 2021-11-24
-$1.50M
derived: sum of 3 quarters · filed 2021-11-24
-$837.00K
derived: sum of 4 quarters · filed 2021-11-24
2019-09-30$1.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24
$4.49M
derived: sum of 2 quarters · filed 2021-11-24
$5.15M
derived: sum of 3 quarters · filed 2021-11-24
$5.75M
10-K · filed 2021-11-24
2019-06-30$2.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-10
$3.36M
derived: sum of 2 quarters · filed 2020-08-10
$3.96M
10-Q · filed 2020-08-10
$4.65M
derived: sum of 4 quarters · filed 2020-11-25
2019-03-31$661.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-11
$1.26M
10-Q · filed 2020-05-11
$1.95M
derived: sum of 3 quarters · filed 2020-11-25
$4.04M
derived: sum of 4 quarters · filed 2020-11-25
2018-12-31$598.00K
10-Q · filed 2020-02-10
$1.29M
derived: sum of 2 quarters · filed 2020-11-25
$3.38M
derived: sum of 3 quarters · filed 2020-11-25
$4.93M
derived: sum of 4 quarters · filed 2020-11-25
2018-09-30$693.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25
$2.78M
derived: sum of 2 quarters · filed 2020-11-25
$4.34M
derived: sum of 3 quarters · filed 2020-11-25
$1.84M
10-K · filed 2020-11-25
2018-06-30$2.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-09
$3.64M
derived: sum of 2 quarters · filed 2019-08-09
$1.15M
10-Q · filed 2019-08-09
$3.45M
derived: sum of 4 quarters · filed 2019-11-27
2018-03-31$1.55M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-10
-$939.00K
10-Q · filed 2019-05-10
$1.36M
derived: sum of 3 quarters · filed 2019-11-27
$1.94M
derived: sum of 4 quarters · filed 2019-11-27
2017-12-31-$2.49M
10-Q · filed 2019-02-08
-$196.00K
derived: sum of 2 quarters · filed 2019-11-27
$387.00K
derived: sum of 3 quarters · filed 2019-11-27
$959.00K
derived: sum of 4 quarters · filed 2019-11-27
2017-09-30$2.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27
$2.88M
derived: sum of 2 quarters · filed 2019-11-27
$3.45M
derived: sum of 3 quarters · filed 2019-11-27
$3.44M
10-K · filed 2019-11-27
2017-06-30$583.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-09
$1.16M
derived: sum of 2 quarters · filed 2018-08-09
$1.15M
10-Q · filed 2018-08-09
$1.06M
derived: sum of 4 quarters · filed 2018-11-29
2017-03-31$572.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-10
$562.00K
10-Q · filed 2018-05-10
$474.00K
derived: sum of 3 quarters · filed 2018-11-29
$2.75M
derived: sum of 4 quarters · filed 2018-11-29
2016-12-31-$10.00K
10-Q · filed 2018-02-09
-$98.00K
derived: sum of 2 quarters · filed 2018-11-29
$2.18M
derived: sum of 3 quarters · filed 2018-11-29
$1.70M
derived: sum of 4 quarters · filed 2018-11-29
2016-09-30-$88.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29
$2.19M
derived: sum of 2 quarters · filed 2018-11-29
$1.71M
derived: sum of 3 quarters · filed 2018-11-29
$1.86M
10-K · filed 2018-11-29
2016-06-30$2.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09
$1.80M
derived: sum of 2 quarters · filed 2017-08-09
$1.95M
10-Q · filed 2017-08-09
$1.33M
derived: sum of 4 quarters · filed 2017-12-11
2016-03-31-$480.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10
-$330.00K
10-Q · filed 2017-05-10
-$948.00K
derived: sum of 3 quarters · filed 2017-12-11
-$166.00K
derived: sum of 4 quarters · filed 2017-12-11
2015-12-31$150.00K
10-Q · filed 2017-02-09
-$468.00K
derived: sum of 2 quarters · filed 2017-12-11
$314.00K
derived: sum of 3 quarters · filed 2017-12-11
$398.00K
derived: sum of 4 quarters · filed 2017-12-11
2015-09-30-$618.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11
$164.00K
derived: sum of 2 quarters · filed 2017-12-11
$248.00K
derived: sum of 3 quarters · filed 2017-12-11
-$227.00K
10-K · filed 2017-12-11
2015-06-30$782.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09
$866.00K
derived: sum of 2 quarters · filed 2016-08-09
$391.00K
10-Q · filed 2016-08-09
$408.00K
derived: sum of 4 quarters · filed 2016-12-09
2015-03-31$84.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10
-$391.00K
10-Q · filed 2016-05-10
-$374.00K
derived: sum of 3 quarters · filed 2016-12-09
$144.00K
derived: sum of 4 quarters · filed 2016-12-09
2014-12-31-$475.00K
10-Q · filed 2016-02-09
-$458.00K
derived: sum of 2 quarters · filed 2016-12-09
$60.00K
derived: sum of 3 quarters · filed 2016-12-09
$659.00K
derived: sum of 4 quarters · filed 2016-12-09
2014-09-30$17.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-09
$535.00K
derived: sum of 2 quarters · filed 2016-12-09
$1.13M
derived: sum of 3 quarters · filed 2016-12-09
-$183.00K
10-K · filed 2016-12-09
2014-06-30$518.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10
$1.12M
derived: sum of 2 quarters · filed 2015-08-10
-$200.00K
10-Q · filed 2015-08-10
$803.00K
derived: sum of 4 quarters · filed 2015-12-11
2014-03-31$599.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08
-$718.00K
10-Q · filed 2015-05-08
$285.00K
derived: sum of 3 quarters · filed 2015-12-11
$366.00K
derived: sum of 4 quarters · filed 2015-12-11
2013-12-31-$1.32M
10-Q · filed 2015-02-06
-$314.00K
derived: sum of 2 quarters · filed 2015-12-11
-$233.00K
derived: sum of 3 quarters · filed 2015-12-11
$474.00K
derived: sum of 4 quarters · filed 2015-12-11
2013-09-30$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11
$1.08M
derived: sum of 2 quarters · filed 2015-12-11
$1.79M
derived: sum of 3 quarters · filed 2015-12-11
-$285.00K
10-K · filed 2015-12-11
2013-06-30$81.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12
$788.00K
derived: sum of 2 quarters · filed 2014-08-12
-$1.29M
10-Q · filed 2014-08-12
-$563.00K
derived: sum of 4 quarters · filed 2014-12-11
2013-03-31$707.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12
-$1.37M
10-Q · filed 2014-05-12
-$644.00K
derived: sum of 3 quarters · filed 2014-12-11
$218.00K
derived: sum of 4 quarters · filed 2014-12-11
2012-12-31-$2.08M
10-Q · filed 2014-02-13
-$1.35M
derived: sum of 2 quarters · filed 2014-12-11
-$489.00K
derived: sum of 3 quarters · filed 2014-12-11
2012-09-30$725.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-11
$1.59M
derived: sum of 2 quarters · filed 2014-12-11
$1.73M
10-K · filed 2014-12-11
2012-06-30$862.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-12
$1.00M
10-Q · filed 2013-08-12
2012-03-31$139.00K
10-Q · filed 2013-05-15
2011-09-30-$1.12M
10-K · filed 2013-12-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Rezolute, Inc. (RZLT)United States$0.382B-6.45
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63